Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03990389 · ClinicalTrials.gov registry record · NA
Tracking Depression Symptoms With a Health Chatbot
A NA study of Depression, Postpartum and Depression, Unipolar, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 2
- Study locations
NCT03990389: Completed NA study of Depression, Postpartum and Depression, Unipolar, sponsored by University of Chicago.
NCT03990389 is a NA study of Depression, Postpartum and Depression, Unipolar that has completed, run by University of Chicago. The registered enrollment target is 31 participants, below the 162-participant average among 15 other Depression, Postpartum trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03990389, a NA study of Depression, Postpartum and Depression, Unipolar, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this research is to bridge a significant "effectiveness" gap in the treatment of depression. The investigators have developed a chatbot which will assist in performing measurement-based care (MBC) via Facebook Messenger. Participants will be randomized to either Usual Care or Usual Care with additional Chatbot Care.
Primary Outcome
Measured by the Edinburgh Postnatal Depression Scale (EPDS) Range 0-30 (dimensionless) Risk of depression goes up with an increasing score
Conditions Studied
Interventions
- DEVICE Chatbot Intervention
Study Locations (2)
Illinois
- University of Chicago - Chicago
- NorthShore University HealthSystem - Skokie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2019-02-20 |
| Est. Completion | 2020-02-29 |
| Phase | NA |
What the finished NCT03990389 record still lists
NCT03990389 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 162-participant average among 15 other Depression, Postpartum trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Depression, Postpartum appearing as the primary indexed condition, and to 1 intervention - of which Chatbot Intervention is the first listed.
NCT03990389 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03990389 about?
NCT03990389 is a clinical study titled "Tracking Depression Symptoms With a Health Chatbot". The goal of this research is to bridge a significant "effectiveness" gap in the treatment of depression. The investigators have developed a chatbot which will assist in performing measurement-based care (MBC) via Facebook Messenger. Participants will be randomized to either Usual Care or Usual Care ...
What is the current status of trial NCT03990389?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2019-02-20. Estimated completion is 2020-02-29.
What conditions does trial NCT03990389 study?
This clinical trial studies the following conditions: Depression, Postpartum, Depression, Unipolar.
What interventions are being tested in trial NCT03990389?
The interventions under investigation include: Chatbot Intervention (DEVICE).
Who is sponsoring clinical trial NCT03990389?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03990389 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression, Postpartum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03990389's enrollment target sits among peer trials
31 15th of 15 higher than 1 of 15 other Depression, Postpartum trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression, Postpartum trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMAGINE: Pilot Trial of a Digital Group Intervention to Prevent Perinatal Depression
RECRUITING · NA
-
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
RECRUITING · NA
-
Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression
RECRUITING · NA
-
Enhancing Mental and Physical Health of Women Veterans
ACTIVE NOT RECRUITING · NA
-
CSE v. Epidural for Postpartum Depression
COMPLETED · NA
-
Doula Support for Young Mothers: A Randomized Trial
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI